Trials / Unknown
UnknownNCT05241626
AS-OCT of the Cornea in Thyroid Diseases
Anterior Segment Optical Coherence Tomography Study of the Tear Film and Cornea in Thyroid Eye Diseases.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
use the anterior segment optical coherence tomography (AS-OCT) to evaluate the tear meniscus parameters, total corneal thickness (CT), and epithelial thickness in active and inactive thyroid eye diseases (TED) patients and compare them with age-matched controls.
Detailed description
A prospective case-control clinical study. The study subjects were divided into 3 groups, group 1 of inactive thyroid patients, group 2 of active thyroid patients, and group 3 of healthy controls. The AS-OCT was used to measure lower tear meniscus parameters (tear meniscus height (TMH), tear meniscus depth (TMD), and tear meniscus area (TMA)), total CT and epithelial thickness
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | AS-OCT | Optical Coherence Tomography (OCT) creates detailed cross-sectional images of the anterior and posterior segments using low coherence interferometry. OCT is a noninvasive, real-time method for evaluating the tear meniscus, total corneal thickness (CT), and corneal epithelial thickness |
Timeline
- Start date
- 2021-05-11
- Primary completion
- 2022-10-29
- Completion
- 2022-10-29
- First posted
- 2022-02-16
- Last updated
- 2022-02-16
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05241626. Inclusion in this directory is not an endorsement.